Glucosamine
Also known as Glucosamine sulfate, Glucosamine HCl
Amino sugar naturally present in cartilage, used as a substrate for glycosaminoglycan synthesis; sulfate-bound formulations have the strongest trial evidence for slowing osteoarthritis symptom progression over months of use.
Reported side effects:Gastrointestinal discomfortConstipationDiarrhoea
Be careful if: some medical situations, certain health conditions, pregnant, breastfeeding
Ask first if you take: blood thinners (anticoagulants or antiplatelets)
Suspect a side effect? Report it to the MHRA Yellow Card scheme ↗
What the research actually shows
We link to relevant studies and leave interpretation to you and your healthcare professional.
Safety and considerations
What sources report about side effects, who should be careful, and medicines to ask about first.
Reported side effects
Serious effects reported
| Reported effect | How often | Basis | Sources |
|---|---|---|---|
| Jaundice | rare | Listed by BNF / NICE | BNF/NICE drug monograph: Glucosamine (licensed products Alateris, Dolenio) |
| Angioedema (frequency not known) | unknown | Listed by BNF / NICE | BNF/NICE drug monograph: Glucosamine (licensed products Alateris, Dolenio) |
Be careful if you…
| Applies to | What sources say | Sources |
|---|---|---|
| some medical situations | Contraindicated if the patient has a shellfish allergy (BNF allergy and cross-sensitivity). | BNF/NICE drug monograph: Glucosamine (licensed products Alateris, Dolenio) |
| certain health conditions | BNF cautions for licensed glucosamine products: asthma; impaired glucose tolerance (monitor blood glucose before treatment and periodically thereafter); predisposition to cardiovascular disease (monitor cholesterol). | BNF/NICE drug monograph: Glucosamine (licensed products Alateris, Dolenio) |
| pregnant | Manufacturers advise avoid in pregnancy — no information available (BNF). | BNF/NICE drug monograph: Glucosamine (licensed products Alateris, Dolenio) |
| breastfeeding | Manufacturers advise avoid while breastfeeding — no information available (BNF). | BNF/NICE drug monograph: Glucosamine (licensed products Alateris, Dolenio) |
Medicines to ask about
| Severity | Medicine | Sources |
|---|---|---|
| ask first | blood thinners (anticoagulants or antiplatelets) — Glucosamine potentially increases the anticoagulant effect of warfarin; manufacturer advises avoid. It also potentially decreases the anticoagulant effect of acenocoumarol. | BNF/NICE interactions: Glucosamine |
Suggested uses (unproven)
Where people report using it and what trials suggest
- Mixed evidenceKnee OA pain (modest subset analyses)
Where the evidence is negative
Common claims the trials do not support
- GAIT trial (n=1,583): no overall benefit vs placebo (small signal only in moderate-to-severe pain subgroup).
- No structural disease modification shown in imaging studies.
- Withdrawal trials show persistent placebo-level response.
Joint-health staple whose rigorous trials have not confirmed structural or symptom benefits beyond placebo for most users.
Evidence grades reflect study quality and consistency, not marketing claims.
Ordered by strength of evidence, then result direction.
01The Safety and Efficacy of Glucosamine and/or Chondroitin in Humans: A Systematic ReviewBaden KER, et al. · Nutrients · 2025PMID 40647198 ↗02Evaluation of efficacy and safety of glucosamine sulfate, chondroitin sulfate, and their combination regimen in the management of knee osteoarthritis: a systematic review and meta-analysisRabade A, et al. · Inflammopharmacology · 2024PMID 38581640 ↗03Dietary supplements for treating osteoarthritis: a systematic review and meta-analysisLiu X, et al. · British journal of sports medicine · 2018PMID 29018060 ↗04Association of Pharmacological Treatments With Long-term Pain Control in Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysisGregori D, et al. · JAMA · 2018PMID 30575881 ↗05Chondroitin for osteoarthritisSingh JA, et al. · The Cochrane database of systematic reviews · 2015PMID 25629804 ↗06Effects of cartilage-supporting nutritional supplementation on knee osteoarthritis symptoms and quality of life in a 12-week randomized double-blind placebo-controlled pilot studyFladerer-Grollitsch JP, et al. · Scientific reports · 2025PMID 40664872 ↗Show all 9 studies
Published research summaries are unavailable.
Why people look into Glucosamine — and what they report
Associated conditions and community-reported outcomes, wrapped together on one page. Aggregates appear only once enough reports arrive.
Where to get Glucosamine (UK)
How this compound is sold in the UK, and where our readers typically find it.
Retailer search links — we may earn commission on purchases at no cost to you. Commission never affects our evidence ratings.